Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group (Q42666936)
Jump to navigation
Jump to search
scientific article published on October 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group |
scientific article published on October 1997 |
Statements
1 reference
Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group (English)
1 reference
Falagas ME
1 reference
Snydman DR
1 reference
Ruthazer R
1 reference
Griffith J
1 reference
Werner BG
1 reference
Freeman R
1 reference
Rohrer R
1 reference
1 October 1997
1 reference
1 reference